Evidence map›Paper›PMID 34515556›Full record

ArticleJournal of dental research2022

Potential Mechanisms Underlying Marijuana-Associated Periodontal Tissue Destruction.

D A Scott, H Dukka, D Saxena

Open access · greenAbstract read
In one paragraph

Article in Journal of dental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Importance of Metalloproteinase 8 (MMP-8) in the Diagnosis of Periodontitis.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

D A ScottOral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, Louisville, KY, USA.
H DukkaDiagnosis and Oral Health, School of Dentistry, University of Louisville, Louisville, KY, USA.
D SaxenaMolecular Pathobiology, College of Dentistry, New York University, New York, USA.
University of Louisville · USNew York University · US

Funding

Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative IntravaginalP20GM125504 · NIGMS · UNIVERSITY OF LOUISVILLE · PI James Tristan Collins · 2018 to 2026
$24.4M
Oral Health Promotion (OHPROM) Strategy for Persons with Intellectual & Developmental DisabilitiesU01DE025833 · NIDCR · UNIVERSITY OF LOUISVILLE · PI DUKKA, HIMABINDU, JOHNSON, KNOWLTON WILLIAM · 2016 to 2020
$3.7M
P. gingivalis genes essential for tobacco smoke survivalR01DE026963 · NIDCR · UNIVERSITY OF LOUISVILLE · PI SCOTT, DAVID A · 2017 to 2024
$2.5M
Regulation of Pancreatic Oncogenesis by the Gut MicrobiomeR01CA206105 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SAXENA, DEEPAK, SIMEONE, DIANE M · 2017 to 2021
$1.9M
A Novel Remedy for Periodontal Bone LossR42DE028212 · NIDCR · PERIOMICS CARE, LLC · PI LI, XIN, SAXENA, DEEPAK · 2022 to 2023
$1.6M
Modulation of oral microenvironment by E-cigarette aerosol mixturesR01DE025992 · NIDCR · NEW YORK UNIVERSITY · PI LI, XIN, SAXENA, DEEPAK · 2016 to 2019
$1.6M
The role of the oral microbiome in disparities in dental caries and responsiveness to caries preventionR56DE028933 · NIDCR · NEW YORK UNIVERSITY · PI RUFF, RYAN RICHARD, SAXENA, DEEPAK · 2020 to 2020
$517k
Filifactor alocis-tobacco interactionsR21DE028506 · NIDCR · UNIVERSITY OF LOUISVILLE · PI SCOTT, DAVID A · 2020 to 2021
$429k
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinomaR41CA250892 · NCI · PERIOMICS CARE, LLC · PI LI, XIN, SAXENA, DEEPAK · 2020 to 2020
$400k
A Novel remedy for periodontal bone lossR41DE028212 · NIDCR · PERIOMICS CARE, LLC · PI LI, XIN, SAXENA, DEEPAK · 2019 to 2019
$224k
NCI NIH HHS R01 CA206105NCI NIH HHS R41 CA250892NIDCR NIH HHS R01 DE025992NIDCR NIH HHS R01 DE026963NIDCR NIH HHS R21 DE028506NIDCR NIH HHS R41 DE028212NIDCR NIH HHS R42 DE028212NIDCR NIH HHS R56 DE028933NIDCR NIH HHS U01 DE025833NIGMS NIH HHS P20 GM125504
6 · The paper itself

Abstract

While definitive evidence awaits, cannabis is emerging as a likely risk factor for periodontal tissue destruction. The mechanisms that underlie potential cannabis-induced or cannabis-enhanced periodontal diseases, however, remain to be elucidated. Herein, we 1) examine insights obtained from the endocannabinoid system, 2) summarize animal models of exposure to cannabinoid receptor agonists and antagonists, 3) review the evidence suggesting that cannabis and cannabis-derived molecules exert a profound influence on components of the oral microbiome, and 4) assess studies indicating that marijuana and phytocannabinoids compromise the immune response to plaque. Furthermore, we address how knowledge of cannabinoid influences in the oral cavity may be exploited to provide potential novel periodontal therapeutics, while recognizing that such medicinal approaches may be most appropriate for nonhabitual marijuana users. The suspected increase in susceptibility to periodontitis in marijuana users is multifaceted, and it is clear that we are only beginning to understand the complex toxicological, cellular, and microbial interactions involved. With marijuana consumption increasing across all societal demographics, periodontal complications of use may represent a significant, growing oral health concern. In preparation, an enhanced research response would seem appropriate.

Indexed as

CannabinoidsCannabisPeriodontitisAnimalsCannabinoid Receptor AgonistsOral HealthCannabinoid Receptor AgonistsCannabinoidsbacteriacell biologyinflammationmicrobiologyperiodontal diseasestoxicology

Identifiers

PMID34515556
PMCPMC8905217
OpenAlexW3199037178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.